Cogentix Medical (NASDAQ: CGNT) reported Q3 EPS of $0.00, $0.04 better than the analyst estimate of ($0.04). Revenue for the quarter came in at $13.4 million versus the consensus estimate of $13.3 million.

For earnings history and earnings-related data on Cogentix Medical (CGNT) click here.